Related Experiment Videos
Course of platelet activation markers after ischemic stroke.
Lars Marquardt1, Andreas Ruf, Ulrich Mansmann
1Department of Neurology, University of Heidelberg, Germany.
Stroke
|November 2, 2002
Summary
Platelet activation markers p-selectin (CD62p) and lysosome-associated membrane protein (CD63) increase after ischemic stroke. CD62p levels decrease rapidly, while CD63 remains elevated, independent of inflammation.
Area of Science:
- Neurology
- Hematology
- Immunology
Background:
- Ischemic stroke triggers complex physiological responses.
- Platelet activation and inflammation are key components of the post-stroke cascade.
- Understanding their temporal dynamics and interrelation is crucial for patient management.
Purpose of the Study:
- To evaluate the time course of platelet activation after ischemic stroke.
- To investigate the correlation between platelet activation and inflammatory markers.
- To identify potential biomarkers for stroke recurrence.
Main Methods:
- Flow cytometry was used to measure platelet expression of p-selectin (CD62p) and lysosome-associated membrane protein (CD63).
- Measurements were taken at 10 time points between days 1 and 90 post-stroke in 50 patients, 30 healthy subjects, and 20 control subjects.
- Leukocyte count, C-reactive protein, and fibrinogen levels were correlated with platelet activation markers.
Main Results:
- CD62p and CD63 expression were significantly higher on day 1 post-stroke compared to controls.
- CD62p expression rapidly declined, while CD63 expression remained elevated up to day 90.
- No correlation was found between platelet activation markers and inflammatory parameters (leukocyte count, CRP, fibrinogen).
Conclusions:
- Platelet activation after stroke shows differential regulation of CD62p and CD63.
- Persistent elevation of CD63 suggests its potential as a predictor for stroke recurrence.
- Platelet activation markers (CD62p, CD63) appear to be regulated independently of systemic inflammatory markers post-stroke.